Biogen Gains Momentum With Positive Lupus Drug Results, Analyst Sees Modest Valuation Upside

Benzinga11/21 02:32

FDA Approves UCB's Psoriasis Drug For Expanded Use In Painful Inflammatory Skin Disease

Benzinga11/21 01:57

UCB Announces U.S. Launch of UCB Myasthenia Gravis Scholarship for People Impacted by Myasthenia Gravis in the U.S.

PR Newswire10/16 02:00

Oruka Draws Buy at Stifel on Potential Against Psoriasis

Seeking Alpha10/12 03:28

Biogen, UCB Mark Late-stage Trial Win for Autoimmune Disease Therapy

Seeking Alpha09/24 18:41

UCB And Biogen Report Results In Phase 3 Lupus Drug Trial

Benzinga09/24 14:48